TW200531703A - Radioactive composition and process for producing radioactive composition - Google Patents

Radioactive composition and process for producing radioactive composition

Info

Publication number
TW200531703A
TW200531703A TW94107315A TW94107315A TW200531703A TW 200531703 A TW200531703 A TW 200531703A TW 94107315 A TW94107315 A TW 94107315A TW 94107315 A TW94107315 A TW 94107315A TW 200531703 A TW200531703 A TW 200531703A
Authority
TW
Taiwan
Prior art keywords
composition
radioactive composition
iomazenil
labelled
producing
Prior art date
Application number
TW94107315A
Other languages
English (en)
Chinese (zh)
Inventor
Hirokatsu Yoshimura
Osamu Ito
Miki Kurami
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of TW200531703A publication Critical patent/TW200531703A/zh

Links

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21HOBTAINING ENERGY FROM RADIOACTIVE SOURCES; APPLICATIONS OF RADIATION FROM RADIOACTIVE SOURCES, NOT OTHERWISE PROVIDED FOR; UTILISING COSMIC RADIATION
    • G21H5/00Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for 
    • G21H5/02Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for  as tracers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0468Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K51/047Benzodiazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
TW94107315A 2004-03-25 2005-03-10 Radioactive composition and process for producing radioactive composition TW200531703A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004090356 2004-03-25

Publications (1)

Publication Number Publication Date
TW200531703A true TW200531703A (en) 2005-10-01

Family

ID=35056001

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94107315A TW200531703A (en) 2004-03-25 2005-03-10 Radioactive composition and process for producing radioactive composition

Country Status (3)

Country Link
JP (1) JP4637096B2 (ja)
TW (1) TW200531703A (ja)
WO (1) WO2005092395A1 (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1318668C (en) * 1988-08-05 1993-06-01 Heinz Carmann Radioiodine benzodiazepine derivatives
US4880615A (en) * 1988-11-25 1989-11-14 Merck & Co., Inc. Stabilized radiopharmaceutical compositions
US7238338B1 (en) * 2001-06-22 2007-07-03 Triumf System and method for the large scale labeling of compounds with radiohalogens

Also Published As

Publication number Publication date
JP4637096B2 (ja) 2011-02-23
WO2005092395A1 (ja) 2005-10-06
JPWO2005092395A1 (ja) 2008-02-07

Similar Documents

Publication Publication Date Title
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
MX2008010921A (es) Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
AR094376A2 (es) Proceso de producción de un compuesto orgánico
WO2007077259A8 (en) Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
AR059296A1 (es) Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona.
WO2008057516A3 (en) Oxygen delivery composition
SI1730144T1 (sl) Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on
TW200744663A (en) Emulsified skin external preparation and method for stabilizing the skin external preparation
DE60310759D1 (de) Pulver auf silber-basis, verfahren zu dessen herstellung, und härtbare siloxanzusammensetzung
MY165041A (en) Composition for improving brain function and method for improving brain function
WO2009138847A3 (en) An improved process for the preparation of cefozopran
MX2012007225A (es) Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
UY29498A1 (es) Derivados de aminoácidos
MXPA05003695A (es) Nuevo proceso para la sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y aplicacion en la sintesis de ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable.
MX2010000693A (es) Composicion farmaceutica que comprende un compuesto de 11-desoxi-prostaglandina y metodo para establilizar el compuesto.
MX2008016272A (es) Procesos de oxidacion mejorados con seguridad mejorada utiles en la fabricacion de moxidectina.
TW200531703A (en) Radioactive composition and process for producing radioactive composition
CR7672A (es) Metodo microbiologico para la produccion de 11- alfa- hidroxiesteroides 7- alfa sustituidos
MX2008011934A (es) Composicion para el tratamiento de enfermedades bacterianas, virales micoticas, inflamacion y dolor.
TW200618815A (en) Manufacturing method for long-term stable L-ascorbic acid cosmetic and its product
BRPI0509213A (pt) método para previnir, reduzir ou minimizar a formação de impurezas de tioamida durante a tionação de um composto de carbonila, produto, e, uso de um agente extrator
EP1123720A3 (en) Organic compound decomposing method
MA32698B1 (fr) Procede de preparation du 1,6:2,3-dianhydro-beta-d-mannopyranose